With upcoming PDUFA, Sage proposes $500M follow-on

With upcoming PDUFA, Sage proposes $500M follow-on

Source: 
BioCentury
snippet: 

CNS disorders company Sage Therapeutics Inc. (NASDAQ:SAGE) proposed Monday to raise $500 million in a follow-on underwritten by Goldman Sachs and J.P. Morgan.